Skip to main content
Premium Trial:

Request an Annual Quote

Where Are They Now?: Oct 1, 2003


Genome Technology’s October 2002 issue was the annual All-Stars edition announcing the winners of the second annual GT All-Stars competition. Last year’s winners — Ruedi Aebersold, Howard Cash, Stephen Fodor, Jim Kent, Martin Leach, Elaine Mardis, Jonathan Rothberg, and Shankar Subramaniam, as well as Affymetrix for company of the year and PerkinElmer’s AcycloPrime as product of the year — have continued to make headlines. Mardis, for instance, was on hand at the NIH earlier this year to help celebrate the completed genome, and Cash still regularly jets from his Michigan office to New York for work on the DNA identification of victims of September 11.

The 2003 GT All-Stars will be featured in the November issue of the magazine. Watch for it in your mailbox next month.

Another article in last year’s magazine looked at Amersham’s CodeLink acquisition and asked whether that would enable the British company to compete with Affymetrix. In this issue, you’ll see that neither of these companies surpassed Applied Biosystems or Agilent in release plans for a single chip containing the entire human genome (see p. 24).

Also appearing last year was the news that Peter Coggins had started at PerkinElmer after leaving Amersham. In the February ’03 issue of Genome Technology, Coggins revealed his plans for the life and analytical sciences unit he heads up — including a new service model where PerkinElmer engineers will provide maintenance for customers’ instruments, even those made by other companies.


The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.